Insider · CIK 0001835973

Nosenzo John

Reports to the SEC for 2 companies · DURHAM, NC

sec.gov

Transactions

Companies

Filings

CIK

0001835973

Forms 4 and 5

Insider transactions

20 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-06-01	TELATELA Bio, Inc.A Award	Director	AAward	+3,135 sh	—	—	6,270
2023-06-01	TELATELA Bio, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+5,360 sh	—	—	5,360
2022-10-03	BVSBioventus Inc.S Sale	Chief Commercial Officer	SSale	−7 sh	$7.00	−$49	87,148
2022-07-01	BVSBioventus Inc.S Sale	Chief Commercial Officer	SSale	−95 sh	$6.73	−$639.35	87,155
2022-06-01	TELATELA Bio, Inc.A Award	Director	AAward	+3,135 sh	—	—	3,135
2022-06-01	TELATELA Bio, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+5,360 sh	—	—	5,360
2022-04-04	BVSBioventus Inc.S Sale	Chief Commercial Officer	SSale	−66K sh	$11.12	−$734K	83,932
2022-04-01	BVSBioventus Inc.S Sale	Chief Commercial Officer	SSale	−40 sh	$14.07	−$562.8	87,250
2022-04-01	BVSBioventus Inc.M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	+106K sh	—	—	149,895
2022-04-01	BVSBioventus Inc. · Restricted Stock UnitsM Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	−106K sh	—	—	0
2022-02-14	BVSBioventus Inc.S Sale	Chief Commercial Officer	SSale	−534 sh	$11.99	−$6,401.325	43,370
2022-02-11	BVSBioventus Inc.M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	+1,470 sh	—	—	43,904
2022-02-11	BVSBioventus Inc. · Restricted Stock UnitsM Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	−1,470 sh	—	—	0
2022-02-10	BVSBioventus Inc.M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	+66.1K sh	—	—	66,639
2022-02-10	BVSBioventus Inc.F Tax Payment	Chief Commercial Officer	FTax Payment	+24.2K sh	$12.88	+$312K	42,434
2022-02-10	BVSBioventus Inc. · Phantom Profit UnitsM Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	−66.1K sh	—	—	0
2021-06-02	TELATELA Bio, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+8,000 sh	—	—	8,000
2021-04-01	BVSBioventus Inc. · Restricted Stock UnitsA Award	Chief Commercial Officer	AAward	+106K sh	—	—	106,485
2021-02-11	BVSBioventus Inc.P Purchase	Chief Commercial Officer	PPurchase	+500 sh	$13.00	+$6,500	500
2021-02-11	BVSBioventus Inc. · Restricted Stock UnitsA Award	Chief Commercial Officer	AAward	+1,470 sh	—	—	1,470

Recent filings

Accepted (ET)
Jun 24
Nosenzo John0001062993-23-012775
SEC(opens sec.gov)
Apr 214
Nosenzo John0001578563-23-000026
SEC(opens sec.gov)
Jun 24
Nosenzo John0001062993-22-014133
SEC(opens sec.gov)
Apr 54
Nosenzo John0000899243-22-013963
SEC(opens sec.gov)
Feb 154
Nosenzo John0000899243-22-006538
SEC(opens sec.gov)
Feb 144
Nosenzo John0000899243-22-006332
SEC(opens sec.gov)
Jun 44
Nosenzo John0001192482-21-000493
SEC(opens sec.gov)
Apr 54
Nosenzo John0000899243-21-014832
SEC(opens sec.gov)
Feb 164
Nosenzo John0000899243-21-006750
SEC(opens sec.gov)

Companies

Address

4721 EMPEROR BOULEVARD SUITE 100

DURHAM, NC, 27703